Literature DB >> 29956139

A Fungal Protease Model to Interrogate Allergic Lung Immunity.

J Morgan Knight1, Evan Li1, Hui-Ying Tung2, Cameron Landers1, Jake Wheeler1, Farrah Kheradmand1,2,3,4, David B Corry5,6,7,8.   

Abstract

Allergic airway diseases (asthma and chronic rhinosinusitis) are among the most common of all human diseases in heavily industrialized societies. Animal models of asthma have provided remarkable insight into allergic disease pathogenesis and will continue to drive the discovery of new therapeutic insights. We provide in this chapter a detailed protocol for inducing allergic immunity in the lungs of mice using a purified fungal protease and include related protocols for assessing immune endpoints.

Entities:  

Keywords:  Airway hyperresponsiveness; Allergic immunity; Asthma; Fungi; Protease; TH2 cell

Mesh:

Substances:

Year:  2018        PMID: 29956139     DOI: 10.1007/978-1-4939-7896-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice.

Authors:  David L Goldblatt; Gabriella Valverde Ha; Shradha Wali; Vikram V Kulkarni; Michael K Longmire; Ana M Jaramillo; Rosha P Chittuluru; Adrienne Fouts; Margarita Martinez-Moczygemba; Jonathan T Lei; David P Huston; Michael J Tuvim; Burton F Dickey; Scott E Evans
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.